|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/25 | |
| A61K 38/00 |
| (11) | Number of the document | 2012809 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07752724.0 |
| Date of filing the European patent application | 2007-03-09 | |
| (97) | Date of publication of the European application | 2009-01-14 |
| (45) | Date of publication and mention of the grant of the patent | 2013-05-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2007/006042 |
| Date | 2007-03-09 |
| (87) | Number | WO 2007/106385 |
| Date | 2007-09-20 |
| (30) | Number | Date | Country code |
| 781172 P | 2006-03-10 | US |
| (72) |
TULIPANO, Giovanni, IT
GIUSTINA, Andrea, IT
DONG, Zheng, Xin, US
CULLER, Michael, Dewitt, US
|
| (73) |
IPSEN PHARMA,
65 Quai Georges Gorse, 92100 Boulogne-Billancourt,
FR
|
| (54) | USE OF A GHRELIN AGONIST TO IMPROVE THE CATABOLIC EFFECTS OF GLUCOCORTICOID TREATMENT |
| USE OF A GHRELIN AGONIST TO IMPROVE THE CATABOLIC EFFECTS OF GLUCOCORTICOID TREATMENT |